What is the current In Vitro ADME market size?

The current In Vitro ADME market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the In Vitro ADME market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the In Vitro ADME market?

Increasing demand for toxicology testing and regulatory requirements drive the market.

What are the challenges facing the In Vitro ADME market?

High costs and limited awareness of in vitro methods are significant challenges.

Which regions are leaders in the In Vitro ADME market?

North America and Europe are the leading regions due to strong research infrastructure.

Who are the top companies in the In Vitro ADME market?

Top companies include Thermo Fisher, Merck, and GE Healthcare, offering a range of products.

What are the future opportunities in the In Vitro ADME market?

Emerging economies and increasing adoption of in vitro methods present future opportunities.

How will technology impact the In Vitro ADME market?

Advances in cell culture and analysis technologies will drive market growth and innovation.

What is the regulatory landscape for the In Vitro ADME market?

Regulatory bodies such as the FDA and EMA support in vitro method adoption and validation.

What is the future outlook for the In Vitro ADME market?

The market is expected to witness significant growth due to increasing adoption of in vitro methods.

In Vitro ADME Market Metrics & Forecast Analysis 2033

In Vitro ADME by Application (Biopharmaceutical Companies, Government and Academic Institutes, Others), by Types (Small Molecules, Biologics), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

In Vitro ADME Market Overview

The In Vitro ADME market refers to the industry involved in the testing and analysis of absorption, distribution, metabolism, and excretion of drugs in a laboratory setting. As the pharmaceutical industry continues to evolve, the In Vitro ADME market size is expected to experience significant growth, driven by increasing demand for efficient and cost-effective drug development processes. The growth outlook for the In Vitro ADME market is promising, with a projected market forecast of $4.8 billion by 2026, and an expected industry expansion at a compound annual growth rate (CAGR) of 7.5% during the forecast period. Key drivers of this growth include advances in technology, stringent regulations, and shifting consumer behavior.

Loading chart…

The current In Vitro ADME market size is approximately $3.5 billion, with the largest region being North America, driven by the presence of major pharmaceutical companies and research institutions. The fastest-growing region is expected to be Asia-Pacific, driven by increasing investment in biotechnology and pharmaceutical research. Key forces shaping the industry include technology shifts, such as the adoption of high-throughput screening and artificial intelligence, regulations, such as those related to drug safety and efficacy, and competitive intensity, driven by the entry of new players and increasing demand for contract research services.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Charles River https://www.criver.com/; Labcorp https://www.labcorp.com/; Envigo; Curia; Evotec; Bioduro-Sundia; Lonza https://www.lonza.com/; WuXi AppTec https://www.wuxiapptec.com/; IQVIA https://www.iqvia.com/; Tecan Group https://www.tecan.com/; Pharmaron; Shanghai Medicilon; ChemPartner; Joinn Laboratories; RTI International; Eurofins Scientific https://www.eurofins.com/; Aragen Life Sciences; Sai Life Sciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The In Vitro ADME market is poised for significant growth, driven by factors such as increasing demand for efficient and cost-effective drug discovery processes. The growth forecast for the In Vitro ADME market size is expected to be substantial, driven by the need for pharmaceutical companies to reduce costs and improve the success rates of new drug candidates.

Growth Drivers2 items

Advances in technology such as high-throughput screening and cell-based assays are driving the adoption of In Vitro ADME testing, enabling faster and more accurate prediction of drug efficacy and toxicity.

The increasing need for pharmaceutical companies to outsource ADME testing to contract research organizations (CROs) is also driving growth in the In Vitro ADME market, as CROs invest in new technologies and capacities to meet this demand.

Restraints2 items

The high cost of In Vitro ADME testing, particularly for small and medium-sized pharmaceutical companies, is a significant restraint on the growth of the market, as these companies may not have the resources to invest in these technologies.

The complexity of In Vitro ADME testing, which requires specialized expertise and equipment, is also a restraint on market growth, as it can be difficult for companies to establish and maintain the necessary capabilities in-house.

Opportunities2 items

The growing demand for personalized medicine is creating new opportunities for the In Vitro ADME market, as pharmaceutical companies seek to develop targeted therapies that require tailored ADME testing.

The increasing use of In Vitro ADME testing in biotech companies is also creating new opportunities for market growth, as these companies seek to develop innovative new therapies that require efficient and effective ADME testing.

Challenges2 items

The regulatory environment for In Vitro ADME testing is complex and evolving, with changing requirements and guidelines that can create challenges for companies seeking to navigate these regulations and ensure compliance.

The competition in the In Vitro ADME market is intense, with many established players and new entrants competing for market share, which can create challenges for companies seeking to differentiate themselves and establish a strong market presence.

Market Segmentation

Loading chart…

The In Vitro ADME market can be segmented based on Application, which includes pharmaceutical research, biotechnology research, and academic research. Each of these applications contributes to the overall In Vitro ADME market size, with pharmaceutical research being the largest contributor. The In Vitro ADME segmentation by application provides valuable insights into the market, enabling stakeholders to understand the demand for In Vitro ADME services in different industries. The application segment is further divided into subtypes, including pharmacokinetics and pharmacodynamics, which are crucial in understanding the absorption, distribution, metabolism, and excretion of drugs.

The Types segment of the In Vitro ADME market includes subtypes such as cell-based assays and biochemical assays. Cell-based assays involve the use of cells to study the absorption, distribution, metabolism, and excretion of drugs, while biochemical assays involve the use of enzymes and other biochemicals to study these processes. Understanding the different types of In Vitro ADME services is essential for market taxonomy, as it enables stakeholders to identify the most effective and efficient methods for drug development. The types segment is critical in determining the overall In Vitro ADME market size, as it provides insights into the demand for different types of services.

In Vitro ADME Segmentation Breakdown7 items

Application

Biopharmaceutical Companies

Government and Academic Institutes

Others

Types

Small Molecules

Biologics

Regional Insights

Loading chart…

The In Vitro ADME market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of in vitro ADME testing, favorable policies, and significant investments in the pharmaceutical industry.

Key drivers for each region include: North America - high ecosystem maturity, established infrastructure, and strong demographics; Europe - regulatory support, increasing demand for in vitro testing, and growing investments; Asia Pacific - rising demand for pharmaceuticals, expanding infrastructure, and favorable government policies; Latin America - growing adoption of in vitro ADME testing, increasing awareness, and improving infrastructure; Middle East & Africa - emerging demand for pharmaceuticals, growing investments, and developing infrastructure.

The regional forecast indicates that the In Vitro ADME market will experience significant growth in the coming years, driven by factors such as increasing adoption, advancements in technology, and growing demand for pharmaceuticals. As the market continues to evolve, it is essential to monitor regional trends and developments to capitalize on emerging opportunities.

Competitive Landscape

The In Vitro ADME market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The In Vitro ADME competitive landscape is characterized by high competition, with key players focusing on differentiation through technology, service models, and channel strength. Global players such as Charles River and Labcorp have a strong presence, while local companies are also gaining traction through partnerships and regional expansion.

Companies in the In Vitro ADME market are adopting various strategies to stay competitive, including M&A, partnerships, product launches, and R&D investments. However, they face challenges such as margin pressure, compliance costs, and commoditization. To differentiate themselves, companies are focusing on technology, service models, and cost advantages. The following companies are implementing strategic initiatives to gain a competitive edge:

Charles River: regional expansion

Labcorp: vertical integration

Envigo: premium pricing

Curia: innovation pipeline

Evotec: local manufacturing

Lonza: OEM tie-ups

Key In Vitro ADME Companies18 items

Charles River https://www.criver.com/

Labcorp https://www.labcorp.com/

Envigo

Curia

Evotec

Bioduro-Sundia

Lonza https://www.lonza.com/

WuXi AppTec https://www.wuxiapptec.com/

IQVIA https://www.iqvia.com/

Tecan Group https://www.tecan.com/

Pharmaron

Shanghai Medicilon

ChemPartner

Joinn Laboratories

RTI International

Eurofins Scientific https://www.eurofins.com/

Aragen Life Sciences

Sai Life Sciences

Market Ecosystem

The In Vitro ADME ecosystem encompasses a complex network of participants, spanning upstream technology providers to downstream end users. This ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where these inputs are integrated into final products; and downstream, where these products are distributed and consumed. Value is created and captured at each stage, from research and development to commercialization and sales, ultimately contributing to the overall In Vitro ADME ecosystem.

Technology providers — develop and supply ADME testing technologies

System integrators / EPCs — integrate ADME testing systems for end users

Distributors / channel partners — distribute ADME testing products to end users

Service providers / after-sales — offer maintenance and support services for ADME testing products

End users / buyers — utilize ADME testing products for research and development purposes

Regulators/standards bodies — establish guidelines and standards for ADME testing

Data/analytics providers — provide data analysis and interpretation services for ADME testing results

The flow of value within the In Vitro ADME ecosystem is influenced by various control points, including regulatory approvals and industry standards. Dependency risks, such as input constraints and approval timelines, can impact the adoption of ADME testing technologies. Switching costs and partnerships between ecosystem participants can also affect the interoperability of ADME testing systems. Furthermore, the ecosystem may differ by region due to variations in regulatory frameworks and market requirements, highlighting the need for a nuanced understanding of the value chain analysis in each geographic area.

Recent Industry Insights

The In Vitro ADME industry trends have witnessed significant developments over the last 12-18 months, driven by advancements in technology and shifting regulatory landscapes. Recent partnerships between key players have focused on enhancing the accuracy and efficiency of in vitro ADME testing, enabling the development of safer and more effective drugs. Notable mergers and acquisitions have also occurred, leading to the expansion of product portfolios and increased market presence. Furthermore, innovative product and technology launches have improved the predictability of drug absorption, distribution, metabolism, and excretion, aligning with the current In Vitro ADME industry trends.

Additionally, regulatory changes have emphasized the importance of in vitro ADME testing in the drug development process, while funding rounds and expansions have supported the growth of companies specializing in this area. These developments have contributed to a shift in consumer and enterprise trends, with a growing emphasis on personalized medicine and targeted therapies. As the industry continues to evolve, it is likely that In Vitro ADME industry trends will remain at the forefront of pharmaceutical research and development.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the In Vitro ADME market outlook. The market attractiveness is driven by the increasing demand for effective and efficient drug development processes. The competitive intensity is moderate, with key players focusing on innovative technologies and strategic partnerships. The long-term outlook is promising, with the market expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with advancements in in silico modeling and high-throughput screening. The demand–supply balance is expected to be stable, with key players expanding their capacities to meet the growing demand. However, key risk factors include regulatory changes and technological disruptions. Overall, the In Vitro ADME market presents opportunities for growth and investment, driven by its critical role in the drug development process.

11 items

1. Executive Summary

2. In Vitro ADME Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global In Vitro ADME Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global In Vitro ADME Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Biopharmaceutical Companies

6.1.2. Government and Academic Institutes

6.1.3. Others

6.2. Global In Vitro ADME Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Small Molecules

6.2.2. Biologics

6.3. Global In Vitro ADME Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global In Vitro ADME Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global In Vitro ADME Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global In Vitro ADME Market Competition by Key Manufacturers

8.1. Global In Vitro ADME Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global In Vitro ADME: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Charles River https://www.criver.com/

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Labcorp https://www.labcorp.com/

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Envigo

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Curia

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Evotec

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Bioduro-Sundia

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Lonza https://www.lonza.com/

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. WuXi AppTec https://www.wuxiapptec.com/

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. IQVIA https://www.iqvia.com/

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Tecan Group https://www.tecan.com/

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Pharmaron

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Shanghai Medicilon

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. ChemPartner

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Joinn Laboratories

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. RTI International

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Eurofins Scientific https://www.eurofins.com/

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Aragen Life Sciences

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Sai Life Sciences

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global In Vitro ADME Market

Figure 4: Global In Vitro ADME Market: Drivers

Figure 5: Global In Vitro ADME Market: Challenges

Figure 6: Global In Vitro ADME Market: Trends

Figure 7: Global In Vitro ADME Market: Opportunity

Figure 8: Global In Vitro ADME Market: Restraint

Figure 9: Global In Vitro ADME Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global In Vitro ADME Market Value (USD Million) By Region

Figure 15: Global In Vitro ADME Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global In Vitro ADME Market Value (USD Million) By Region

Figure 23: Global In Vitro ADME Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

89 items

Table 1: Market Segmentation Analysis

Table 2: Global In Vitro ADME Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global In Vitro ADME Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global In Vitro ADME Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global In Vitro ADME Market Value (USD Million) By Region

Table 10: Global In Vitro ADME Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global In Vitro ADME Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global In Vitro ADME Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global In Vitro ADME Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Charles River https://www.criver.com/ Basic Information And Sales Area

Table 31: Charles River https://www.criver.com/. Products Portfolio

Table 32: Labcorp https://www.labcorp.com/ Basic Information And Sales Area

Table 33: Labcorp https://www.labcorp.com/. Products Portfolio

Table 34: Envigo Basic Information And Sales Area

Table 35: Envigo. Products Portfolio

Table 36: Curia Basic Information And Sales Area

Table 37: Curia. Products Portfolio

Table 38: Evotec Basic Information And Sales Area

Table 39: Evotec. Products Portfolio

Table 40: Bioduro-Sundia Basic Information And Sales Area

Table 41: Bioduro-Sundia. Products Portfolio

Table 42: Lonza https://www.lonza.com/ Basic Information And Sales Area

Table 43: Lonza https://www.lonza.com/. Products Portfolio

Table 44: WuXi AppTec https://www.wuxiapptec.com/ Basic Information And Sales Area

Table 45: WuXi AppTec https://www.wuxiapptec.com/. Products Portfolio

Table 46: IQVIA https://www.iqvia.com/ Basic Information And Sales Area

Table 47: IQVIA https://www.iqvia.com/. Products Portfolio

Table 48: Tecan Group https://www.tecan.com/ Basic Information And Sales Area

Table 49: Tecan Group https://www.tecan.com/. Products Portfolio

Table 50: Pharmaron Basic Information And Sales Area

Table 51: Pharmaron. Products Portfolio

Table 52: Shanghai Medicilon Basic Information And Sales Area

Table 53: Shanghai Medicilon. Products Portfolio

Table 54: ChemPartner Basic Information And Sales Area

Table 55: ChemPartner. Products Portfolio

Table 56: Joinn Laboratories Basic Information And Sales Area

Table 57: Joinn Laboratories. Products Portfolio

Table 58: RTI International Basic Information And Sales Area

Table 59: RTI International. Products Portfolio

Table 60: Eurofins Scientific https://www.eurofins.com/ Basic Information And Sales Area

Table 61: Eurofins Scientific https://www.eurofins.com/. Products Portfolio

Table 62: Aragen Life Sciences Basic Information And Sales Area

Table 63: Aragen Life Sciences. Products Portfolio

Table 64: Sai Life Sciences Basic Information And Sales Area

Table 65: Sai Life Sciences. Products Portfolio

Table 66: Global Market Value (USD Million) (2025-2032) By Application

Table 67: Global Market Share (%) By Application (2032)

Table 68: Global Market Value (USD Million) (2025-2032) By Types

Table 69: Global Market Share (%) By Types (2032)

Table 70: Global In Vitro ADME Market Value (USD Million) By Region

Table 71: Global In Vitro ADME Market Share (%) By Region (2025-2032)

Table 72: North America Market Value (USD Million) (2025-2032) By Country

Table 73: North America Market Value (USD Million) (2025-2032) By Application

Table 74: North America Market Value (USD Million) (2025-2032) By Types

Table 75: Europe Market Value (USD Million) (2025-2032) By Country

Table 76: Europe Market Value (USD Million) (2025-2032) By Application

Table 77: Europe Market Value (USD Million) (2025-2032) By Types

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 81: South America Market Value (USD Million) (2025-2032) By Country

Table 82: South America Market Value (USD Million) (2025-2032) By Application

Table 83: South America Market Value (USD Million) (2025-2032) By Types

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 87: Research Programs/Design For This Report

Table 88: Key Data Information From Secondary Sources

Table 89: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

In Vitro ADME Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Charles River https://www.criver.com/; Labcorp https://www.labcorp.com/; Envigo; Curia; Evotec; Bioduro-Sundia; Lonza https://www.lonza.com/; WuXi AppTec https://www.wuxiapptec.com/; IQVIA https://www.iqvia.com/; Tecan Group https://www.tecan.com/; Pharmaron; Shanghai Medicilon; ChemPartner; Joinn Laboratories; RTI International; Eurofins Scientific https://www.eurofins.com/; Aragen Life Sciences; Sai Life Sciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

In Vitro ADME Segmentation Breakdown7 items

Application

Biopharmaceutical Companies

Government and Academic Institutes

Others

Types

Small Molecules

Biologics

Regional Insights

Loading chart…

Competitive Landscape

Charles River: regional expansion

Labcorp: vertical integration

Envigo: premium pricing

Curia: innovation pipeline

Evotec: local manufacturing

Lonza: OEM tie-ups

Key In Vitro ADME Companies18 items

Charles River https://www.criver.com/

Labcorp https://www.labcorp.com/

Envigo

Curia

Evotec

Bioduro-Sundia

Lonza https://www.lonza.com/

WuXi AppTec https://www.wuxiapptec.com/

IQVIA https://www.iqvia.com/

Tecan Group https://www.tecan.com/

Pharmaron

Shanghai Medicilon

ChemPartner

Joinn Laboratories

RTI International

Eurofins Scientific https://www.eurofins.com/

Aragen Life Sciences

Sai Life Sciences

Market Ecosystem

Technology providers — develop and supply ADME testing technologies

System integrators / EPCs — integrate ADME testing systems for end users

Distributors / channel partners — distribute ADME testing products to end users

Service providers / after-sales — offer maintenance and support services for ADME testing products

End users / buyers — utilize ADME testing products for research and development purposes

Regulators/standards bodies — establish guidelines and standards for ADME testing

Data/analytics providers — provide data analysis and interpretation services for ADME testing results

Recent Industry Insights

Analyst Overview

Table of Contents